XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders’ Equity - USD ($)
Convertible Preferred Stock
Common Stock
Common Stock Warrants
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 220 $ 10 $ 114,159,150 $ (100,355,194) $ 13,804,186
Balance (in Shares) at Dec. 31, 2019 21,982,491 949,086        
Exercise of stock options 623 623
Exercise of stock options (in Shares)   2,708        
Stock-based compensation 131,732 131,732
Net loss (8,338,807) (8,338,807)
Balance at Dec. 31, 2020 $ 220 $ 10 114,291,505 (108,694,001) 5,597,734
Balance (in Shares) at Dec. 31, 2020 21,982,491 951,794        
Exercise of stock options 14,220 $ 14,220
Exercise of stock options (in Shares)   53,395       109,902
Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110 $ 35 23,295,855 $ 23,295,890
Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110 (in Shares)   3,500,000        
Conversion of convertible preferred stock to common stock in connection with initial public offering $ (220) $ 220
Conversion of convertible preferred stock to common stock in connection with initial public offering (in Shares) (21,982,491) 21,982,491        
Stock-based compensation 1,139,247 1,139,247
Issuance of warrants     170,397 (170,397)  
Net loss (7,799,529) (7,799,529)
Balance at Dec. 31, 2021 $ 265 $ 170,397 $ 138,570,430 $ (116,493,530) $ 22,247,562
Balance (in Shares) at Dec. 31, 2021   26,487,680